Article of Diagen, Inc. by Kyunghyang Shinmun, 2018.10.09 

A Domestic company(Diagen, Inc) developed early diagnosis technology for Chronic Hepatitis and 

Liver Fibrosis by measuring concentration of transformed glycoprotein transformed from Liver synthesized glycoprotein. 

It can monitor progress of Liver function aggravation in (Non)Alcoholic steatosis hepatitis patients, which its number grows rapidly.

It is a technology that can be done in relatively inexpensively. 

Original Article : http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201810092046015&code=900303